Dimensional Fund Advisors
UTMD icon

Dimensional Fund Advisors’s Utah Medical Products UTMD Stock Holding History

Dimensional Fund Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3M Buy
197,908
+1,399
+0.7% +$88.1K ﹤0.01% 2178
2025
Q4 		$11M Sell
196,509
-3,523
-2% -$204K ﹤0.01% 2251
2025
Q3 		$12.6M Buy
200,032
+2,566
+1% +$152K ﹤0.01% 2214
2025
Q2 		$11.2M Buy
197,466
+4,508
+2% +$245K ﹤0.01% 2235
2025
Q1 		$10.8M Buy
192,958
+6,258
+3% +$375K ﹤0.01% 2220
2024
Q4 		$11.5M Buy
186,700
+11,196
+6% +$724K ﹤0.01% 2256
2024
Q3 		$11.7M Buy
175,504
+5,194
+3% +$353K ﹤0.01% 2236
2024
Q2 		$11.4M Buy
170,310
+8,700
+5% +$592K ﹤0.01% 2209
2024
Q1 		$11.5M Sell
161,610
-1,434
-0.9% -$108K ﹤0.01% 2252
2023
Q4 		$13.7M Buy
163,044
+3,128
+2% +$259K ﹤0.01% 2171
2023
Q3 		$13.8M Buy
159,916
+4,789
+3% +$442K ﹤0.01% 2099
2023
Q2 		$14.5M Buy
155,127
+589
+0.4% +$55.5K ﹤0.01% 2087
2023
Q1 		$14.6M Buy
154,538
+1,170
+0.8% +$108K ﹤0.01% 2056
2022
Q4 		$15.4K Buy
153,368
+445
+0.3% +$40.6K ﹤0.01% 1991
2022
Q3 		$13M Sell
152,923
-29
-0% -$2.56K 0.01% 2047
2022
Q2 		$13.1M Buy
152,952
+3,259
+2% +$278K ﹤0.01% 2085
2022
Q1 		$13.5M Sell
149,693
-408
-0.3% -$37.5K ﹤0.01% 2169
2021
Q4 		$15M Sell
150,101
-1,400
-0.9% -$143K ﹤0.01% 2142
2021
Q3 		$14.1M Sell
151,501
-689
-0.5% -$60.9K ﹤0.01% 2171
2021
Q2 		$12.9M Sell
152,190
-1,111
-0.7% -$96.1K ﹤0.01% 2242
2021
Q1 		$13.3M Sell
153,301
-8,505
-5% -$748K ﹤0.01% 2215
2020
Q4 		$13.6M Sell
161,806
-4,533
-3% -$386K ﹤0.01% 2158
2020
Q3 		$13.3M Sell
166,339
-3,231
-2% -$268K 0.01% 2062
2020
Q2 		$15M Sell
169,570
-785
-0.5% -$70.5K 0.01% 2020
2020
Q1 		$16M Sell
170,355
-540
-0.3% -$50.2K 0.01% 1880
2019
Q4 		$18.4M Sell
170,895
-1,524
-0.9% -$154K 0.01% 2080
2019
Q3 		$16.5M Sell
172,419
-200
-0.1% -$18.6K 0.01% 2114
2019
Q2 		$16.5M Sell
172,619
-3,949
-2% -$332K 0.01% 2164
2019
Q1 		$15.6M Buy
176,568
+954
+0.5% +$83.9K 0.01% 2195
2018
Q4 		$14.6M Buy
175,614
+2,336
+1% +$206K 0.01% 2158
2018
Q3 		$16.3M Buy
173,278
+1,820
+1% +$174K 0.01% 2227
2018
Q2 		$18.9M Buy
171,458
+3,191
+2% +$333K 0.01% 2129
2018
Q1 		$16.6M Buy
168,267
+4,365
+3% +$389K 0.01% 2153
2017
Q4 		$13.3M Buy
163,902
+1,654
+1% +$129K 0.01% 2252
2017
Q3 		$11.9M Buy
162,248
+2,596
+2% +$187K 0.01% 2294
2017
Q2 		$11.6M Buy
159,652
+5,305
+3% +$349K 0.01% 2288
2017
Q1 		$9.62M Sell
154,347
-538
-0.3% -$33.9K ﹤0.01% 2343
2016
Q4 		$11.3M Sell
154,885
-2,393
-2% -$156K 0.01% 2244
2016
Q3 		$9.4M Sell
157,278
-28
-0% -$1.78K 0.01% 2280
2016
Q2 		$9.91M Buy
157,306
+1,006
+0.6% +$64.9K 0.01% 2232
2016
Q1 		$9.78M Buy
156,300
+2,592
+2% +$153K 0.01% 2216
2015
Q4 		$9M Buy
153,708
+901
+0.6% +$51.1K 0.01% 2275
2015
Q3 		$8.23M Buy
152,807
+395
+0.3% +$21.5K 0.01% 2315
2015
Q2 		$9.09M Buy
152,412
+59
+0% +$3.32K 0.01% 2313
2015
Q1 		$9.12M Sell
152,353
-100
-0.1% -$5.88K 0.01% 2281
2014
Q4 		$9.15M Buy
152,453
+1,607
+1% +$89K 0.01% 2301
2014
Q3 		$7.36M Sell
150,846
-400
-0.3% -$20.3K 0.01% 2366
2014
Q2 		$7.78M Buy
151,246
+5,156
+4% +$265K 0.01% 2371
2014
Q1 		$8.45M Buy
146,090
+430
+0.3% +$23.5K 0.01% 2296
2013
Q4 		$8.33M Sell
145,660
-1,897
-1% -$104K 0.01% 2298
2013
Q3 		$8.77M Sell
147,557
-1,154
-0.8% -$63K 0.01% 2215
2013
Q2 		$8.07M Buy
+148,711
New +$7M 0.01% 2194

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors's UTMD Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Utah Medical Products (UTMD) stake by 0.71% in Q1 2026, buying an estimated $88.1K and bringing the position to 197,908 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

Dimensional Fund Advisors first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.9M in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Dimensional Fund Advisors held 197,908 shares of Utah Medical Products worth $12.3M as of Q1 2026.
  • Dimensional Fund Advisors bought 1,399 Utah Medical Products shares in Q1 2026, an estimated $88.1K.
  • Utah Medical Products made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2178 holding.
  • Dimensional Fund Advisors first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Utah Medical Products position peaked at $18.9M in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.